Aft Forsyth & Sober’s Thermo Fisher Scientific TMO Stock Holding History

Aft Forsyth & Sober’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,075	Closed	-$1.6M	–	80
2024 Q4	$1.6M	Hold	3,075	–	–	0.52%	49
2024 Q3	$1.9M	Hold	3,075	–	–	0.63%	46
2024 Q2	$1.7M	Hold	3,075	–	–	0.58%	50
2024 Q1	$1.79M	Hold	3,075	–	–	0.63%	50
2023 Q4	$1.63M	Hold	3,075	–	–	0.63%	50
2023 Q3	$1.56M	Hold	3,075	–	–	0.66%	43
2023 Q2	$1.6M	Hold	3,075	–	–	0.67%	40
2023 Q1	$1.77M	Hold	3,075	–	–	0.9%	29
2022 Q4	$1.69M	Hold	3,075	–	–	0.76%	33
2022 Q3	$1.56M	Hold	3,075	–	–	0.76%	34
2022 Q2	$1.67M	Hold	3,075	–	–	0.78%	30
2022 Q1	$1.82M	Hold	3,075	–	–	0.72%	34
2021 Q4	$2.05M	Hold	3,075	–	–	0.72%	30
2021 Q3	$1.76M	Buy	3,075 +1,050	+52%	+$576K	0.66%	33
2021 Q2	$1.02M	Hold	2,025	–	–	0.38%	67
2021 Q1	$924K	Buy	2,025 +975	+93%	+$465K	0.38%	71
2020 Q4	$489K	Buy	+1,050	New	+$492K	0.38%	56
2020 Q3	–	Sell	-125	Closed	-$45K	–	53
2020 Q2	$45K	Buy	+125	New	+$41.9K	0.32%	35
2020 Q1	–	Sell	-370	Closed	-$120K	–	63
2019 Q4	$120K	Buy	+370	New	+$112K	0.11%	27

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Aft Forsyth & Sober's TMO Position: Q1 2025 in Review

Aft Forsyth & Sober sold out of Thermo Fisher Scientific (TMO) in Q1 2025, closing a stake of 3,075 shares — an estimated $1.6M sold.

Aft Forsyth & Sober first reported a position in TMO in Q4 2019 and held it in 19 quarters. The position peaked at $2.05M in Q4 2021. 2,570 funds tracked by Wall St. Rank hold TMO as of Q1 2025.

Aft Forsyth & Sober reported no remaining Thermo Fisher Scientific position as of Q1 2025 after selling out during the quarter.
Aft Forsyth & Sober sold 3,075 Thermo Fisher Scientific shares in Q1 2025, an estimated $1.6M.
Aft Forsyth & Sober first reported a position in Thermo Fisher Scientific in Q4 2019 and held it in 19 quarters.
Aft Forsyth & Sober's Thermo Fisher Scientific position peaked at $2.05M in Q4 2021.
2,570 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.

Based on Aft Forsyth & Sober's 13F filing for Q1 2025, filed 12 May 2025.